KCNMA1 and nervous system disorder: The studies of human genetics on BK channelopathy, biophysical characterizations, and the animal models carrying either GOF or LOF BK channel mutations indicate that BK channels can be a promising drug target for treating associated neurological diseases (Du et al., 2020; Dong et al., 2021).